Prenatal testosterone exposure induces insulin resistance, uterine oxidative stress and pro-inflammatory status in rats

Mol Cell Endocrinol. 2021 Jan 1:519:111045. doi: 10.1016/j.mce.2020.111045. Epub 2020 Oct 23.

Abstract

Prenatal androgen excess is considered one of the main causes of the development of polycystic ovary syndrome. In this study, we investigated the effect of prenatal hyperandrogenization (PH) on the physiology of the adult uterine tissue using a murine model of fetal programming caused by androgen excess in adult female rats. Pregnant rats were hyperandrogenized with testosterone and female offspring were studied when adult. Our results showed that PH leads to hyperglycemia and hyperinsulinemia. Consequently, PH developed insulin resistance and a systemic inflammatory state reflected by increased C-reactive protein. In the uterine tissue, levels of PPAR gamma-an important metabolic sensor in the endometrium-were found to be impaired. Moreover, PH induced a pro-inflammatory and an unbalanced oxidative state in the uterus reflected by increased COX-2, lipid peroxidation, and NF-κB. In summary, our results revealed that PH leads to a compromised metabolic state likely consequence of fetal reprogramming.

Keywords: Fetal programming; Inflammation; Oxidative stress; Prenatal hyperandrogenization; Uterus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens / adverse effects
  • Animals
  • Antioxidants / metabolism
  • Biomarkers / metabolism
  • Cyclooxygenase 2 / metabolism
  • Female
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Inflammation / pathology*
  • Insulin Resistance*
  • Organ Size
  • Oxidation-Reduction
  • Oxidative Stress*
  • PPAR gamma / metabolism
  • Phosphorylation
  • Pregnancy
  • Prenatal Exposure Delayed Effects / pathology*
  • Rats
  • Rats, Sprague-Dawley
  • Testosterone / adverse effects*
  • Uterus / metabolism
  • Uterus / pathology*

Substances

  • Androgens
  • Antioxidants
  • Biomarkers
  • PPAR gamma
  • Testosterone
  • Cyclooxygenase 2
  • Glycogen Synthase Kinase 3 beta